If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelical Bar Regulatory News (HLCL)

Share Price Information for Helical Bar (HLCL)

Share Price is delayed by 15 minutes
Get Live Data
199.20    7.40 (3.86%)
Bid:
195.20
Ask:
201.00
Spread: 5.80 (2.971%)
Market Cap: £241.25m
HLCL Live PriceLast checked at - London Stock Exchange

Intraday Helical Bar Share Chart

Changes to Board & Committee Composition

11 Feb 2022 07:00

RNS Number : 3502B
Helical PLC
11 February 2022
 

11 February 2022

HELICAL PLC

("Helical" or the "Company")

Changes to Board & Committee Composition

 

As reported in the Company's 2021 Annual Report and Accounts, Richard Grant is standing down as Board Chairman, Nominations Committee Chair and Director of the Company at the 2022 AGM.

 

Following an internal recruitment process led by a specially convened Nominations Committee and advised by Sam Allen Associates, an external search consultancy, Helical is pleased to announce the appointment of Richard Cotton as independent Non-Executive Chairman Designate. Subject to Shareholder approval, it is intended that he will succeed Richard Grant, becoming Chairman of the Board following the conclusion of the 2022 AGM, scheduled to take place in July 2022. Upon becoming Chairman, Richard Cotton will also become Chair of the Nominations Committee and step down from the Audit and Risk Committee. Richard Cotton will continue to serve as the Company's Senior Independent Director and as a member of the Nominations Committee, the Remuneration Committee and the Audit and Risk Committee until the 2022 AGM.

Richard Cotton joined the Board as a Non-Executive Director in March 2016 and became Senior Independent Director in February 2018. Richard's biography is available on the Company's website.

It is proposed that Richard Cotton will hand over his duties as Senior Independent Director to Sue Clayton with effect from the conclusion of the 2022 AGM. Sue has been an Independent Non-Executive Director on the Board of Helical since February 2016. Sue's biography is also available on the Company's website.

Following these proposed changes to the Board's composition, the Helical Board will consist of four independent Non-Executive Directors, including the Chairman designate and three Executive Directors.

 

This announcement is made pursuant to LR 9.6.11R of the Listing Rules.

 

For further information, please contact:

 

Tim Murphy (Finance Director)

 

Tel: 020 7629 0113

 

 

Date of notification: 11 February 2022

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAURUNRUSUUAAR
Date   Source Headline
14th Feb 20257:00 amRNSDEVELOPMENT FUNDING AGREED FOR 10 KING WILLIAM ST
13th Feb 20257:00 amRNSJAMES MOSS TO SUCCEED TIM MURPHY AS CFO OF HELICAL
3rd Feb 20259:19 amRNSDirector/PDMR Shareholding
16th Jan 20258:59 amRNSDirector/PDMR Shareholding
9th Dec 20247:00 amRNSChange of registered office address
2nd Dec 202412:06 pmRNSDirector/PDMR Shareholding
2nd Dec 202410:55 amRNS2025 Interim Dividend Timetable Correction
26th Nov 20247:00 amRNSHalf-year Report
1st Nov 20247:00 amRNSSALE OF INTEREST IN THE JJ MACK BUILDING
14th Oct 20247:00 amRNSTrading Update
25th Sep 20248:00 amRNSNotice of Results
7th Aug 20242:38 pmRNSDirector/PDMR Shareholding
17th Jul 20249:58 amRNSResult of AGM
17th Jul 20247:00 amRNSTrading Update
5th Jul 20247:00 amRNSDirector/PDMR Shareholding
20th Jun 20249:17 amRNSNotice of AGM & 2024 Annual Report & Accounts
17th Jun 20244:53 pmRNSDirector/PDMR Shareholding
10th Jun 20241:35 pmRNSMajor Shareholding Notification
28th May 20243:02 pmRNSMajor shareholding notifications
28th May 20249:02 amRNSMajor shareholding notifications
23rd May 20247:00 amRNSAnnual Results for the Year to 31 March 2024
23rd May 20247:00 amRNSDirectorate Change
20th May 20247:00 amRNSSALE OF 50% STAKE IN 100 NEW BRIDGE STREET
22nd Apr 20247:00 amRNSTrading Update
4th Apr 202410:00 amRNSListing Rule 9.6.14(2) Disclosure
25th Mar 20247:00 amRNSHELICAL AGREES SALE OF 25 CHARTERHOUSE SQUARE
15th Mar 20247:00 amRNSThree Crowns signs lease at The JJ Mack Building
14th Mar 20244:31 pmRNSDirector/PDMR Shareholding
8th Feb 20249:15 amRNSChanges to Board and Committee Composition
23rd Jan 20243:59 pmRNSDirector/PDMR Shareholding
16th Jan 202411:09 amRNSDirector/PDMR Shareholding
15th Jan 202410:27 amRNSMajor Shareholding Notification
11th Jan 20244:06 pmRNSMajor Shareholding Notification
9th Jan 20247:00 amRNSTrading Update
6th Dec 20238:34 amRNSHolding(s) in Company
5th Dec 20237:00 amRNSSainsbury's signs lease at The JJ Mack Building
30th Nov 20233:57 pmRNSHolding(s) in Company
29th Nov 20232:53 pmRNSDirector/PDMR Shareholding
22nd Nov 20237:00 amRNSHalf-year Report
1st Nov 202312:28 pmRNSWeWork Update
13th Sep 20235:15 pmRNSHolding(s) in Company
13th Sep 20237:00 amRNSDirector/PDMR Shareholding
24th Aug 20238:00 amRNSNotice of Results
1st Aug 20237:00 amRNSNotification of Interests of Directors and PDMRs
19th Jul 20232:41 pmRNSHolding(s) in Company
13th Jul 202311:36 amRNSResult of AGM
13th Jul 20237:00 amRNSTrading Update
12th Jul 20237:00 amRNSHelical signs contract for office portfolio JV
20th Jun 20237:00 amRNSDirector/PDMR Shareholding
13th Jun 20237:00 amRNSNotice of AGM & 2023 Annual Report & Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.